Volume 18, Number 1—January 2012
Letter
Pulmonary Infection Caused by Mycobacterium conceptionense
Table
Patient no. | Age, y/ sex | Underlying illness | Clinical presentation | M. conceptionense source | Sequencing results† | Treatment | Outcome | Ref |
---|---|---|---|---|---|---|---|---|
1 | 69/F | Chronic lung disease | Chronic cough and recurrent fever; multifocal lung lesion and lymphadenopathy seen on chest CT image | Sputum (2×) | tuf, 16S rDNA (1,441 and 458 bp; 100% match) | CLA, RIF, EMB | Improved after 2 mo treatment | This article |
2 | 70/M | Parkinson disease | Asymptomatic; small nodule seen on chest CT image | Sputum (1×) | tuf | CLA | Asymptomatic | This article |
3 | 70/M | Tongue cancer | Respiratory failure, Streptococcus pneumoniae septicemia; lung lesion on chest CT image | Sputum (2×) | tuf, 16S rDNA (400 and 460 bp; 100% match) | CLA, LVX, IPM, AMK, VAN | Died | This article |
4 | 53/M | Lung tuberculosis | Asymptomatic after completion of antituberculosis treatment | Sputum (1×) | tuf, 16S rDNA (459 bp; 100% match) | Observation | Asymptomatic | This article |
5‡ | 31/F | Posttraumatic osteitis | Wound liquid outflow 3 mo after treatment for open fracture | Wound liquid, bone tissue biopsy, excised skin tissue | 16S rDNA, soda, hsp65, recA, rpoB | AMC | Not reported | (1) |
6‡ | 43/F | Subcutaneous abscess without trauma | Painful swelling and erythematous ankle; abscess detected by MRI | Abscess aspirate | 16S rDNA (1,464 bp) | COT, CLA, DOX, LIN | Improved after 5 mo treatment | (2) |
7‡ | 58/F | Breast implant infection | Fever and wound discharge | Wound discharge, surgical drainage | rpoB | CIP, AZY, DOX | Unremarkable results at 2-mo follow-up after 18 mo treatment | (3) |
8 | 50/F | Face surgery with fat grafting | Erythematous nodules and purulent discharge | Wound discharge | 16S rDNA, rpoB | AMK, LVX, CFX, CLA, SXT | Recovered after 1 mo treatment | (4) |
*Ref, reference; CT, computed tomography; CLA, clarithromycin; RIF, rifampin; EMB, ethambutol; LVX, levofloxacin; IPM, imipenem; AMK, amikacin; VAN, vancomycin; AMC, amoxicillin/clavulanic acid; MRI, magnetic resonance imaging COT, cotrimoxazole; DOX, doxycycline; LIN, linezolid; CIP, ciprofloxacin; AZY, azithromycin; CFX, cefoxitin; SXT, sulfamethoxazole/trimethoprim.
†Sequences of the isolates were compared with the tuf gene and 16S rDNA gene sequence of the type strain CIP 108544T (GenBank accession nos. EU191943.1 and AY859684.1, respectively).
‡Data modified from Thibeaut et al. (3).
References
- Adékambi T, Stein A, Carvajal J, Raoult D, Drancourt M. Description of Mycobacterium conceptionense sp. nov., a Mycobacterium fortuitum group organism isolated from a posttraumatic osteitis inflammation. J Clin Microbiol. 2006;44:1268–73. DOIPubMedGoogle Scholar
- Liao CH, Lai CC, Huang YT, Chou CH, Hsu HL, Hsueh PR. Subcutaneous abscess caused by Mycobacterium conceptionense in an immunocompetent patient. J Infect. 2009;58:308–9. DOIPubMedGoogle Scholar
- Thibeaut S, Levy PY, Pelletier ML, Drancourt M. Mycobacterium conceptionense infection after breast implant surgery, France. Emerg Infect Dis. 2010;16:1180–1. DOIPubMedGoogle Scholar
- Yang HJ, Yim HW, Lee MY, Ko KS, Yoon HJ. Mycobacterium conceptionense infection complicating face rejuvenation with fat grafting. J Med Microbiol. 2011;60:371–4. DOIPubMedGoogle Scholar
- Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol. 2000;38:2966–71.PubMedGoogle Scholar
- Kang SH, Yoo KC, Park KU, Song J, Kim EC. Usefulness of multiplex real-time PCR and melting curve analysis in identification of nontuberculous mycobacteria. Korean J Lab Med. 2007;27:40–5. DOIPubMedGoogle Scholar
- Kim M, Heo SR, Choi SH, Kwon H, Park JS, Seong MW, Comparison of the MicroScan, VITEK 2, and Crystal GP with 16S rRNA sequencing and MicroSeq 500 v2.0 analysis for coagulase-negative staphylococci. BMC Microbiol. 2008;8:233. DOIPubMedGoogle Scholar
- Mignard S, Flandrois JP. Identification of Mycobacterium using the EF-Tu encoding (tuf) gene and the tmRNA encoding (ssrA) gene. J Med Microbiol. 2007;56:1033–41. DOIPubMedGoogle Scholar
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. DOIPubMedGoogle Scholar
- Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009;49:e124–9. DOIPubMedGoogle Scholar
Page created: December 15, 2011
Page updated: December 15, 2011
Page reviewed: December 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.